Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-24 @ 5:47 PM
NCT ID:
NCT03325868
Eligibility Criteria:
Inclusion Criteria
* 18-51 years old
* PBAC score greater than 100
* Ultrasound or MRI findings of adenomyosis
Exclusion Criteria
* Inability to comprehend written and/or spoken English or Spanish
* Inability to provide informed consent
* Current uterine, breast, cervical or ovarian cancer
* Unwilling to use contraception
* Positive pregnancy test or planning pregnancy during the study period
* Submucosal uterine fibroids (or greater than a certain size)
* Current premalignancy or malignancy
* Endometrial ablation or uterine artery embolization
* Known hemoglobinopathy
* Known severe coagulation disorder
* Large uterine polyp (\>2cm)
* BMI \>40
* Previous or current treatment with SPRM or GnRH agonist
* Progestins, acetylsalicylic acid, mefenamic acid, anticoagulants, antifibrinolytic drugs, systemic glucocorticoids within 1 month of enrollment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
51 Years
Study:
NCT03325868
Study Brief:
Protocol Section:
NCT03325868